CORTEX PHARMACEUTICALS INC/DE/ (COR) is a publicly traded company in the Unknown sector. Across all available filings, 76 corporate insiders have executed 1086 transactions totaling $8.0B, demonstrating a bearish sentiment with -$8.0B in net insider flow. The most recent transaction on Jan 20, 2026 involved a transaction of 3,763 shares valued at $0.
No significant insider buying has been recorded for COR in the recent period.
No significant insider selling has been recorded for COR in the recent period.
Based on recent SEC filings, insider sentiment for COR is bearish with an Insider Alignment Score of 0/100 and a net flow of -$8.0B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CORTEX PHARMACEUTICALS INC/DE/ (COR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 76 insiders are actively trading COR stock, having executed 1086 transactions in the past 90 days. The most active insider is Boots Alliance Holdings Llc Walgreens (Executive), who has made 3 transactions totaling $1.7B.
Get notified when executives and directors at COR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | P. Mauch Robert | Executive | Option Exercise | 3,763 | $N/A | $0 | |
| Jan 20, 2026 | P. Mauch Robert | Executive | Sale | 5,096 | $354.73 | $1.8M | Large |
| Jan 20, 2026 | P. Mauch Robert | Executive | Option Exercise | 3,763 | $86.09 | $324.0K | |
| Dec 19, 2025 | S. Campbell Elizabeth | Executive | Sale | 3,351 | $342.10 | $1.1M | Large |
| Dec 19, 2025 | Battaglia Silvana | Executive | Sale | 1,677 | $345.00 | $578.6K | Large |
| Dec 18, 2025 | P. Mauch Robert | Executive | Option Exercise | 3,763 | $86.09 | $324.0K | |
| Dec 18, 2025 | P. Mauch Robert | Executive | Sale | 5,096 | $343.45 | $1.8M | Large |
| Dec 17, 2025 | M. Nally Dennis | Executive | Gift | 1,173 | $N/A | $0 | |
| Dec 17, 2025 | F. Cleary James | Executive | Payment | 26,952 | $344.15 | $9.3M | Large |
| Dec 17, 2025 | F. Cleary James | Executive | Option Exercise | 45,154 | $86.09 | $3.9M | Large |
| Dec 17, 2025 | Krikorian Lazarus | Executive | Sale | 4,031 | $343.24 | $1.4M | Large |
| Dec 17, 2025 | P. Mauch Robert | Executive | Gift | 3,000 | $N/A | $0 | |
| Dec 15, 2025 | Krikorian Lazarus | Executive | Payment | 91 | $350.32 | $31.9K | |
| Dec 15, 2025 | Krikorian Lazarus | Executive | Option Exercise | 91 | $N/A | $0 | |
| Dec 15, 2025 | F. Cleary James | Executive | Payment | 199 | $350.32 | $69.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 516 | $8.0B | 98.4% |
Payment(F) | 73 | $74.0M | 0.9% |
Exercise(M) | 169 | $52.4M | 0.6% |
Purchase(P) | 37 | $1.9M | 0.0% |
Award(A) | 236 | $559.8K | 0.0% |
Small Acquisition(L) | 5 | $10.1K | 0.0% |
Gift(G) | 13 | $0 | 0.0% |
Disposition(D) | 37 | $0 | 0.0% |
Insider selling pressure at CORTEX PHARMACEUTICALS INC/DE/ has increased, with 76 insiders executing 1086 transactions across all time. Total sales of $8.0B significantly outpace purchases of $1.9M, resulting in a net outflow of $8.0B. This selling activity appears largely discretionary, which may warrant closer attention from investors.